Table 4. Baseline characteristics of patients in TCGA-LUAD dataset with complete clinical information.
| Clinical features | Mean ± SD/n |
|---|---|
| Risk score | 2.119±0.05303 |
| Age (years) | 64.56±10.29 |
| Follow time (days) | 554.5±341.5 |
| Sex | |
| Male | 71 |
| Female | 90 |
| Tumor status | |
| Tumor free | 115 |
| With tumor | 46 |
| Histologic diagnosis | |
| LUAD-NOS | 102 |
| LUAD-specified | 59 |
| Residual tumor | |
| R0 | 142 |
| R1 | 8 |
| Rx | 11 |
| Stage | |
| I | 89 |
| II | 37 |
| III | 28 |
| IV | 7 |
| T | |
| T1 | 57 |
| T2 | 84 |
| T3 | 12 |
| T4 | 6 |
| Tx | 2 |
| N | |
| N0 | 101 |
| N+ | 60 |
| M | |
| M0 | 112 |
| M1 | 7 |
| Mx | 42 |
| Subdivision | |
| R | 94 |
| L | 67 |
TCGA, The Cancer Genome Atlas; LUAD, lung adenocarcinoma; NOS, not-otherwise-specified; SD, standard deviation.